MedTrace Logo

Overcoming Racial Disparities in Screening Mammography

NCT07549139 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2026-05-18

No results posted yet for this study

Summary

The purpose of this study is to increase screening mammography among Black women by implementing and evaluating a culturally tailored patient-centric program designed to address barriers to screening. By performing a randomized clinical trial, this study aims to develop effective strategies to improve adherence to screening mammography and contribute to reducing health disparities in breast cancer outcomes.

Conditions

Interventions

OTHER

Appointment mail reminder

Patient will receive an appointment reminder in the mail 7-10 days prior to the appointment.

OTHER

Telephone counseling

The telephone counseling will include an appointment reminder within 7 days of their appointment and identify and troubleshoot barriers to patient's mammography completion.

OTHER

Digital navigation video

The digital navigation video will explain the rationale for the mammogram and the mammography procedure. Digital navigation video will be sent by SMS text message 1-3 days prior to the appointment.

OTHER

Automated phone call

Patient will receive an automated reminder phone call for their appointment 1-3 days prior to the appointment.

Sponsors & Collaborators

Principal Investigators

  • Foluso Ademuyiwa, MD, MPH, MSCI · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07549139 on ClinicalTrials.gov